Table 3.
Evaluation of outcomes
| Chronic disease | Outcomes | Number of studies demonstrating efficacy |
| Dementia | Agitation | 4 |
| Resident engagement | 3 | |
| Depression | 1 | |
| Discontinued antipsychotics | 1 | |
| Functional status | 1 | |
| Pain/discomfort | 1 | |
| Time on task | 1 | |
| Affect | 1 | |
| Nursing assessments | 1 | |
| Quality of life | 0 | |
| Neuropsychiatric symptoms | 0 | |
| Diabetes | Insulin dose | 1 |
| Physician assessments | 1 | |
| Preventative screening | 1 | |
| Hypoglycaemia | 0 | |
| Pharmacotherapy | 0 | |
| Congestive heart failure | Availability of echocardiogram | 1 |
| Pharmacotherapy | 1 | |
| Nursing assessments | 1 | |
| Immunisation rates | 1 | |
| Education | 1 |